Osteoarthritis: quantification of the receptor activator of nuclear factor kappa-β ligand (RANKL) in synovial fluid of Thoroughbred horses
DOI:
https://doi.org/10.15381/rivep.v30i2.16084Keywords:
osteoarthritis; equine; RANKL; RANK; NF-kβ; osteoclastogenesisAbstract
Osteoarthritis (OA) is a disease of great impact that produces functional disability at an early age in racehorses where its diagnosis is usually carried out in advanced stages of the disease. The aim of this study was to demonstrate the presence of the activating receptor ligand of nuclear factor kappa-β (RANKL) in synovial fluid of equines in training. Three healthy horses of two years and four horses of 3-4 years of age with signs of joint inflammation were evaluated clinically and radiographically. Synovial fluid was extracted to quantify the expression of RANKL in different pathological states of the carpus by an ELISA test. The average value of RANKL in healthy horses was 33.13 ± 8.30 pg/ml and in horses with OA signs of 49.03 ± 5.95 pg/ml (p<0.05).
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Luis De Negri, Luis Olguín, Leonardo Pavez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
AUTHORS RETAIN THEIR RIGHTS:
a. Authors retain their trade mark rights and patent, and also on any process or procedure described in the article.
b. Authors retain their right to share, copy, distribute, perform and publicly communicate their article (eg, to place their article in an institutional repository or publish it in a book), with an acknowledgment of its initial publication in the Revista de Investigaciones Veterinarias del Perú (RIVEP).
c. Authors retain theirs right to make a subsequent publication of their work, to use the article or any part thereof (eg a compilation of his papers, lecture notes, thesis, or a book), always indicating the source of publication (the originator of the work, journal, volume, number and date).
